Lombard Medical (EVAR) Misses Q2 EPS by 2c; Revises FY16 Revenue Outlook

August 22, 2016 4:02 PM EDT
Get Alerts EVAR Hot Sheet
Price: $0.65 +1.56%

Today's EPS Names:
PG, CFG, GE, More
Trade EVAR Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Lombard Medical (NASDAQ: EVAR) reported Q2 EPS of ($0.42), $0.02 worse than the analyst estimate of ($0.40). Revenue for the quarter came in at $3.8 million versus the consensus estimate of $3.8 million.

Due to the suspension of the US commercial operation, Lombard feels it is also prudent to amend its revenue guidance for the year to between $13 million and $15 million, driven in the second half by continued procedure and revenue growth in the Company’s go-forward core markets of Europe and Japan.

**** The Street sees FY16 revenue of $17.6 million.

For earnings history and earnings-related data on Lombard Medical (EVAR) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Guidance

Related Entities


Add Your Comment